BOSTON SCIENTIFIC CORPORATION (BSX) Free cash flow
- Free cash flow · 12 months (USD): Value $3.63B; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value 17.27%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $3.63B | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $4.53B − $904.00M ≈ $3.63B |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 17.27% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $3.63B ÷ $21.00B × 100 ≈ 17.27% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $4.53B | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | (m) | Operating cash flow / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 4.53B USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 904.00M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 3.63B USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 21.00B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | (m) | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.63B | (m) | $4.53B | $904.00M | (m) | $21.00B | (m) | (m) | (m) | (m) | 17.27% | (m) |
| 2026-03-31 | $3.48B | (m) | $4.34B | $866.00M | (m) | $20.61B | (m) | (m) | (m) | (m) | 16.86% | (m) |
| 2025-12-31 | $3.66B | (m) | $4.53B | $876.00M | (m) | $20.07B | (m) | (m) | (m) | (m) | 18.22% | (m) |
| 2025-09-30 | $3.82B | (m) | $4.63B | $802.00M | (m) | $19.35B | (m) | (m) | (m) | (m) | 19.76% | (m) |
| 2025-06-30 | $3.48B | (m) | $4.29B | $800.00M | (m) | $18.49B | (m) | (m) | (m) | (m) | 18.84% | (m) |
| 2025-03-31 | $3.01B | (m) | $3.81B | $798.00M | (m) | $17.55B | (m) | (m) | (m) | (m) | 17.17% | (m) |
| 2024-12-31 | $2.65B | (m) | $3.44B | $790.00M | (m) | $16.75B | (m) | (m) | (m) | (m) | 15.79% | (m) |
| 2024-09-30 | $2.16B | (m) | $2.94B | $780.00M | (m) | $15.91B | (m) | (m) | (m) | (m) | 13.55% | (m) |
| 2024-06-30 | $1.84B | (m) | $2.63B | $791.00M | (m) | $15.23B | (m) | (m) | (m) | (m) | 12.09% | (m) |
| 2024-03-31 | $1.70B | (m) | $2.48B | $779.00M | (m) | $14.71B | (m) | (m) | (m) | (m) | 11.55% | (m) |
| 2023-12-31 | $1.79B | (m) | $2.50B | $711.00M | (m) | $14.24B | (m) | (m) | (m) | (m) | 12.58% | (m) |
| 2023-09-30 | $1.70B | (m) | $2.35B | $656.00M | (m) | $13.76B | (m) | (m) | (m) | (m) | 12.34% | (m) |
| 2023-06-30 | $1.51B | (m) | $2.13B | $616.00M | (m) | $13.40B | (m) | (m) | (m) | (m) | 11.26% | (m) |
| 2023-03-31 | $1.20B | (m) | $1.77B | $578.00M | (m) | $13.04B | (m) | (m) | (m) | (m) | 9.17% | (m) |
| 2022-12-31 | $938.00M | (m) | $1.53B | $588.00M | (m) | $12.68B | (m) | (m) | (m) | (m) | 7.40% | (m) |
| 2022-09-30 | $555.00M | (m) | $1.20B | $642.00M | (m) | $12.57B | (m) | (m) | (m) | (m) | 4.42% | (m) |
| 2022-06-30 | $593.00M | (m) | $1.19B | $599.00M | (m) | $12.33B | (m) | (m) | (m) | (m) | 4.81% | (m) |
| 2022-03-31 | $928.00M | (m) | $1.53B | $600.00M | (m) | $12.16B | (m) | (m) | (m) | (m) | 7.63% | (m) |
| 2021-12-31 | $1.32B | (m) | $1.87B | $554.00M | (m) | $11.89B | (m) | (m) | (m) | (m) | 11.07% | (m) |
| 2021-09-30 | $1.62B | (m) | $2.06B | $447.00M | (m) | $11.47B | (m) | (m) | (m) | (m) | 14.11% | (m) |
| 2021-06-30 | $1.85B | (m) | $2.24B | $389.00M | (m) | $11.20B | (m) | (m) | (m) | (m) | 16.56% | (m) |
| 2021-03-31 | $1.52B | (m) | $1.87B | $351.00M | (m) | $10.12B | (m) | (m) | (m) | (m) | 15.00% | (m) |
| 2020-12-31 | $1.13B | (m) | $1.51B | $376.00M | (m) | $9.91B | (m) | (m) | (m) | (m) | 11.42% | (m) |
| 2020-09-30 | $1.12B | (m) | $1.53B | $403.00M | (m) | $10.11B | (m) | (m) | (m) | (m) | 11.12% | (m) |
| 2020-06-30 | $911.00M | (m) | $1.39B | $475.00M | (m) | $10.16B | (m) | (m) | (m) | (m) | 8.97% | (m) |
| 2020-03-31 | $911.00M | (m) | $1.41B | $498.00M | (m) | $10.79B | (m) | (m) | (m) | (m) | 8.45% | (m) |
| 2019-12-31 | $1.38B | (m) | $1.84B | $461.00M | (m) | $10.73B | (m) | (m) | (m) | (m) | 12.81% | (m) |
| 2019-09-30 | $782.00M | (m) | $1.16B | $381.00M | (m) | $10.39B | (m) | (m) | (m) | (m) | 7.53% | (m) |
| 2019-06-30 | $826.00M | (m) | $1.16B | $336.00M | (m) | $10.08B | (m) | (m) | (m) | (m) | 8.20% | (m) |
| 2019-03-31 | $148.00M | (m) | $467.00M | $319.00M | (m) | $9.94B | (m) | (m) | (m) | (m) | 1.49% | (m) |
| 2018-12-31 | $-6.00M | (m) | $310.00M | $316.00M | (m) | $9.82B | (m) | (m) | (m) | (m) | -0.06% | (m) |
| 2018-09-30 | $686.00M | (m) | $975.00M | $289.00M | (m) | $9.67B | (m) | (m) | (m) | (m) | 7.09% | (m) |
| 2018-06-30 | $653.00M | (m) | $926.00M | $273.00M | (m) | $9.50B | (m) | (m) | (m) | (m) | 6.87% | (m) |
| 2018-03-31 | $1.36B | (m) | $1.63B | $267.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $1.11B | (m) | $1.43B | $319.00M | (m) | $9.05B | (m) | (m) | (m) | (m) | 12.23% | (m) |
| 2017-09-30 | $613.00M | (m) | $1.02B | $407.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $316.00M | (m) | $734.00M | $418.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $542.00M | (m) | $970.00M | $428.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $596.00M | (m) | $972.00M | $376.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $541.00M | (m) | $835.00M | $294.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $981.00M | (m) | $1.27B | $293.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $652.00M | (m) | $913.00M | $261.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $353.00M | (m) | $600.00M | $247.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $470.00M | (m) | $711.00M | $241.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $422.00M | (m) | $649.00M | $227.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $628.00M | (m) | $874.00M | $246.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $1.01B | (m) | $1.27B | $259.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $812.00M | (m) | $1.08B | $264.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $716.00M | (m) | $981.00M | $265.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $842.00M | (m) | $1.09B | $251.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $837.00M | (m) | $1.08B | $245.00M | (m) | $7.14B | (m) | (m) | (m) | (m) | 11.72% | (m) |
| 2013-09-30 | $955.00M | (m) | $1.18B | $223.00M | (m) | $7.13B | (m) | (m) | (m) | (m) | 13.40% | (m) |
| 2013-06-30 | $988.00M | (m) | $1.20B | $212.00M | (m) | $7.13B | (m) | (m) | (m) | (m) | 13.87% | (m) |
| 2013-03-31 | $998.00M | (m) | $1.21B | $213.00M | (m) | $7.14B | (m) | (m) | (m) | (m) | 13.97% | (m) |
| 2012-12-31 | $1.03B | (m) | $1.26B | $226.00M | (m) | $7.25B | (m) | (m) | (m) | (m) | 14.26% | (m) |
| 2012-09-30 | $993.00M | (m) | $1.24B | $247.00M | (m) | $7.28B | (m) | (m) | (m) | (m) | 13.65% | (m) |
| 2012-06-30 | $1.06B | (m) | $1.33B | $270.00M | (m) | $7.42B | (m) | (m) | (m) | (m) | 14.35% | (m) |
| 2012-03-31 | $1.02B | (m) | $1.32B | $301.00M | (m) | $7.56B | (m) | (m) | (m) | (m) | 13.43% | (m) |
| 2011-12-31 | $704.00M | (m) | $1.01B | $304.00M | (m) | $7.62B | (m) | (m) | (m) | (m) | 9.24% | (m) |
| 2011-09-30 | $824.00M | (m) | $1.11B | $284.00M | (m) | $7.78B | (m) | (m) | (m) | (m) | 10.60% | (m) |
| 2011-06-30 | $323.00M | (m) | $616.00M | $293.00M | (m) | $7.82B | (m) | (m) | (m) | (m) | 4.13% | (m) |
| 2011-03-31 | $241.00M | (m) | $512.00M | $271.00M | (m) | $7.77B | (m) | (m) | (m) | (m) | 3.10% | (m) |
| 2010-12-31 | $53.00M | (m) | $325.00M | $272.00M | (m) | $7.81B | (m) | (m) | (m) | (m) | 0.68% | (m) |
| 2010-09-30 | $-749.00M | (m) | $-453.00M | $296.00M | (m) | $7.88B | (m) | (m) | (m) | (m) | -9.50% | (m) |
| 2010-06-30 | $-152.00M | (m) | $157.00M | $309.00M | (m) | $7.99B | (m) | (m) | (m) | (m) | -1.90% | (m) |
| 2010-03-31 | $-32.00M | (m) | $290.00M | $322.00M | (m) | $8.14B | (m) | (m) | (m) | (m) | -0.39% | (m) |
| 2009-12-31 | $523.00M | (m) | $835.00M | $312.00M | (m) | $8.19B | (m) | (m) | (m) | (m) | 6.39% | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $854.00M | (m) | $1.22B | $362.00M | (m) | $8.05B | (m) | (m) | (m) | (m) | 10.61% | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $571.00M | (m) | $934.00M | $363.00M | (m) | $8.36B | (m) | (m) | (m) | (m) | 6.83% | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |